Ana Patiño-García Selected Research

Chimeric Antigen Receptors

7/2020	[Immunotherapy with CAR-T cells in paediatric haematology-oncology].
10/2017	Memory T Cells Expressing an NKG2D-CAR Efficiently Target Osteosarcoma Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Patiño-García Research Topics

Disease

28	Neoplasms (Cancer) 01/2022 - 03/2002
15	Osteosarcoma (Osteogenic Sarcoma) 03/2021 - 05/2009
5	Glioma (Gliomas) 01/2022 - 01/2016
5	Neoplasm Metastasis (Metastasis) 01/2018 - 05/2003
3	Diffuse Intrinsic Pontine Glioma 01/2022 - 01/2017
3	Breast Neoplasms (Breast Cancer) 01/2018 - 09/2013
3	Carcinogenesis 10/2012 - 03/2002
2	Ovarian Neoplasms (Ovarian Cancer) 02/2022 - 09/2013
2	Lymphoma (Lymphomas) 01/2020 - 10/2012
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 04/2014
2	Cardiotoxicity 01/2018 - 12/2017
1	Sarcoma (Soft Tissue Sarcoma) 10/2021
1	Adenocarcinoma of Lung 03/2021
1	B-Cell Lymphoma (Lymphoma, B Cell) 07/2020
1	Stroke (Strokes) 01/2020
1	Brain Neoplasms (Brain Tumor) 01/2020
1	Hemorrhage 01/2020
1	Primitive Neuroectodermal Tumors (PNET) 10/2019
1	Renal Cell Carcinoma (Grawitz Tumor) 10/2019
1	Refractive Errors (Refractive Error) 01/2019
1	Heart Failure 01/2018
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2018
1	Familial Breast Cancer 04/2015
1	Infections 10/2012
1	Bipolar Disorder (Manic Depressive Psychosis) 05/2012
1	Mental Disorders (Mental Disorder) 05/2012
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2012
1	Overweight 07/2008

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 10/2021 - 03/2002
7	Proteins (Proteins, Gene)FDA Link 10/2019 - 08/2009
6	dipinacoline glutamateIBA 01/2022 - 01/2017
4	Pharmaceutical PreparationsIBA 03/2021 - 01/2015
3	LigandsIBA 01/2022 - 08/2009
3	DNA (Deoxyribonucleic Acid)IBA 03/2021 - 04/2014
3	Small Interfering RNA (siRNA)IBA 10/2020 - 10/2012
2	CollagenIBA 10/2020 - 10/2003
2	Chimeric Antigen ReceptorsIBA 07/2020 - 10/2017
2	Cell-Free Nucleic AcidsIBA 01/2020 - 01/2019
2	ErbB Receptors (EGF Receptor)IBA 01/2019 - 10/2012
2	edelfosineIBA 01/2018 - 01/2017
2	Lipid NanoparticlesIBA 01/2018 - 01/2017
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018 - 01/2017
2	AnthracyclinesIBA 01/2018 - 12/2017
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 02/2022
1	CytokinesIBA 03/2021
1	Interleukin-12 (IL 12)IBA 03/2021
1	HLA-A Antigens (HLA-A)IBA 03/2021
1	AminopropionitrileIBA 10/2020
1	N 30IBA 01/2020
1	Therapeutic UsesIBA 10/2019
1	Sunitinib (Sutent)FDA Link 10/2019
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2019
1	Tyrosine Kinase InhibitorsIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2018
1	FluoridesIBA 11/2018
1	SodiumIBA 11/2018
1	Electron-Transferring Flavoproteins (Electron Transfer Flavoprotein)IBA 01/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	EuropiumIBA 10/2017
1	Formaldehyde (Formol)FDA Link 01/2017
1	ParaffinIBA 01/2017
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 01/2016
1	1-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA 01/2016
1	Matrix Gla ProteinIBA 01/2016
1	Mitochondrial DNA (mtDNA)IBA 04/2015
1	Drug CarriersIBA 01/2015
1	LipidsIBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 10/2014
1	Pemetrexed (MTA)FDA Link 04/2014
1	Thymidylate SynthaseIBA 04/2014
1	imidazole mustard (BIC)IBA 09/2013
1	NucleotidesIBA 09/2013
1	CateninsIBA 01/2013
1	Oncogene Proteins (Oncogene Protein)IBA 01/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 10/2012
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2012
1	UbiquitinIBA 10/2012
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 10/2012
1	Proto-Oncogene Proteins c-cblIBA 10/2012
1	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 05/2012
1	RNA (Ribonucleic Acid)IBA 01/2012
1	CortactinIBA 01/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2009
1	OsteoprotegerinIBA 08/2009
1	ezrinIBA 08/2009
1	alpha-Crystallin B ChainIBA 08/2009
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 05/2009
1	EnzymesIBA 05/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 05/2009
1	Methotrexate (Mexate)FDA LinkGeneric 05/2009
1	Reduced Folate Carrier ProteinIBA 05/2009
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 07/2008
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 07/2008

Therapy/Procedure

10	Therapeutics 01/2022 - 01/2015
7	Drug Therapy (Chemotherapy) 01/2019 - 03/2002
3	Oncolytic Virotherapy 01/2022 - 10/2019
2	Radiotherapy 01/2022 - 01/2019
1	Transplantation 10/2020
1	Oral Administration 01/2018
1	Adjuvant Chemotherapy 01/2015